TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
55.83
+2.20 (4.10%)
At close: Jun 26, 2026, 4:00 PM EDT
55.80
-0.03 (-0.05%)
After-hours: Jun 26, 2026, 7:59 PM EDT
TG Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 52.67, with a low estimate of 17 and a high estimate of 83. The average target predicts a decrease of -5.66% from the current stock price of 55.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TG Therapeutics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Reiterates $57 → $83 | Buy | Reiterates | $57 → $83 | +48.67% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $70 | Buy | Maintains | $70 | +25.38% | Jun 9, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $17 | Sell | Maintains | $17 | -69.55% | Jun 4, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $55 | Buy | Reiterates | $55 | -1.49% | Jun 4, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $41 | Hold | Maintains | $41 | -26.56% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
941.40M
from 616.29M
Increased by 52.75%
Revenue Next Year
1.23B
from 941.40M
Increased by 30.42%
EPS This Year
1.54
from 2.77
Decreased by -44.58%
EPS Next Year
2.87
from 1.54
Increased by 87.09%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 966.5M | 1.4B | |
| Avg | 941.4M | 1.2B | |
| Low | 923.0M | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.8% | 46.4% | |
| Avg | 52.8% | 30.4% | |
| Low | 49.8% | 13.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.67 | 3.58 | |
| Avg | 1.54 | 2.87 | |
| Low | 1.30 | 2.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -39.7% | 133.2% | |
| Avg | -44.6% | 87.1% | |
| Low | -53.1% | 51.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.